These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


380 related items for PubMed ID: 8913541

  • 1. The diversified pharmacology of angiotensin II-receptor blockade.
    Timmermans PB, Smith RD.
    Blood Press Suppl; 1996; 2():53-61. PubMed ID: 8913541
    [Abstract] [Full Text] [Related]

  • 2. Discovery of losartan, the first angiotensin II receptor antagonist.
    Timmermans PB, Duncia JV, Carini DJ, Chiu AT, Wong PC, Wexler RR, Smith RD.
    J Hum Hypertens; 1995 Nov; 9 Suppl 5():S3-18. PubMed ID: 8583479
    [Abstract] [Full Text] [Related]

  • 3. Historical development of losartan (DuP 753) and angiotensin II receptor subtypes.
    Wong PC, Timmermans PB.
    Blood Press Suppl; 1996 Nov; 3():11-4. PubMed ID: 8973760
    [Abstract] [Full Text] [Related]

  • 4. Effect of angiotensin II blockade on cardiac hypertrophy and remodelling: a review.
    Dahlöf B.
    J Hum Hypertens; 1995 Nov; 9 Suppl 5():S37-44. PubMed ID: 8583480
    [Abstract] [Full Text] [Related]

  • 5. A new class of therapeutic agents: the angiotensin II receptor antagonists.
    Timmermans PB, Smith RD.
    Cardiologia; 1994 Dec; 39(12 Suppl 1):397-400. PubMed ID: 7634303
    [Abstract] [Full Text] [Related]

  • 6. Angiotensin II receptor inhibition. A new therapeutic principle.
    Messerli FH, Weber MA, Brunner HR.
    Arch Intern Med; 1996 Sep 23; 156(17):1957-65. PubMed ID: 8823149
    [Abstract] [Full Text] [Related]

  • 7. Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure.
    Levy BI, Benessiano J, Henrion D, Caputo L, Heymes C, Duriez M, Poitevin P, Samuel JL.
    J Clin Invest; 1996 Jul 15; 98(2):418-25. PubMed ID: 8755652
    [Abstract] [Full Text] [Related]

  • 8. Blockade of the renin-angiotensin system in heart failure in conscious dogs.
    Murakami M, Suzuki H, Naitoh M, Matsumoto A, Kageyama Y, Tsujimoto G, Saruta T.
    J Hypertens; 1995 Dec 15; 13(12 Pt 1):1405-12. PubMed ID: 8866902
    [Abstract] [Full Text] [Related]

  • 9. The advantages of angiotensin II antagonism.
    Burnier M, Waeber B, Brunner HR.
    J Hypertens Suppl; 1994 Jul 15; 12(2):S7-15. PubMed ID: 7965267
    [Abstract] [Full Text] [Related]

  • 10. Acute myocardial and vascular responses to specific angiotensin II antagonism in the spontaneously hypertensive rat.
    Cody RJ, Binkley PF, Haas GJ, Brown DM.
    Am J Hypertens; 1995 May 15; 8(5 Pt 1):500-8. PubMed ID: 7662227
    [Abstract] [Full Text] [Related]

  • 11. The angiotensin II receptor antagonist losartan: a new advance in the treatment of hypertension.
    Lacourcière Y.
    Can J Cardiol; 1995 Aug 15; 11 Suppl F():45F-48F. PubMed ID: 7664218
    [Abstract] [Full Text] [Related]

  • 12. Angiotensin II antagonists: a new class of antihypertensive agent.
    Waeber B, Brunner HR.
    Br J Clin Pract; 1996 Aug 15; 50(5):265-8. PubMed ID: 8794603
    [Abstract] [Full Text] [Related]

  • 13. New perspectives in angiotensin system control.
    Timmermans PB, Wong PC, Chiu AT, Herblin WF, Smith RD.
    J Hum Hypertens; 1993 Aug 15; 7 Suppl 2():S19-31. PubMed ID: 8230085
    [Abstract] [Full Text] [Related]

  • 14. Angiotensin II receptors and angiotensin II receptor antagonists.
    Timmermans PB, Wong PC, Chiu AT, Herblin WF, Benfield P, Carini DJ, Lee RJ, Wexler RR, Saye JA, Smith RD.
    Pharmacol Rev; 1993 Jun 15; 45(2):205-51. PubMed ID: 8372104
    [No Abstract] [Full Text] [Related]

  • 15. The future role of losartan.
    Hansson L.
    J Hum Hypertens; 1995 Nov 15; 9 Suppl 5():S55-8. PubMed ID: 8583483
    [Abstract] [Full Text] [Related]

  • 16. Role of angiotensin II in blood pressure regulation and in the pathophysiology of cardiovascular disorders.
    Fyhrquist F, Metsärinne K, Tikkanen I.
    J Hum Hypertens; 1995 Nov 15; 9 Suppl 5():S19-24. PubMed ID: 8583476
    [Abstract] [Full Text] [Related]

  • 17. [Losartan and the LIFE-study. Antihypertensive treatment with AT1-receptor antagonist].
    Kjeldsen SE, Omvik P.
    Tidsskr Nor Laegeforen; 1996 Feb 10; 116(4):504-7. PubMed ID: 8644056
    [Abstract] [Full Text] [Related]

  • 18. [Antagonists of angiotensin II receptor].
    Karasek D, Adamski M, Grzeszczak W.
    Postepy Hig Med Dosw; 1996 Feb 10; 50(1):21-32. PubMed ID: 8778711
    [Abstract] [Full Text] [Related]

  • 19. Anti-hypertensive therapy by losartan. How effective is AT1 receptor blockade?
    Brunner HR.
    J Hum Hypertens; 1995 Nov 10; 9(11):859-60. PubMed ID: 8583462
    [No Abstract] [Full Text] [Related]

  • 20. Losartan (Cozaar).
    Baldinger S.
    Conn Med; 1996 May 10; 60(5):281-4. PubMed ID: 8998906
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.